cyc 202 has been researched along with stallimycin in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (stallimycin) | Trials (stallimycin) | Recent Studies (post-2010) (stallimycin) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 485 | 0 | 39 |
| Protein | Taxonomy | cyc 202 (IC50) | stallimycin (IC50) |
|---|---|---|---|
| GTPase HRas | Homo sapiens (human) | 0.2 | |
| Estrogen receptor | Homo sapiens (human) | 0.02 | |
| Neutrophil elastase | Homo sapiens (human) | 0.2 | |
| DNA topoisomerase 1 | Homo sapiens (human) | 2.7 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C | 1 |
1 other study(ies) available for cyc 202 and stallimycin
| Article | Year |
|---|---|
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic | 2015 |